403 related articles for article (PubMed ID: 26177278)
1. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
Levine DE; Karia PS; Schmults CD
JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients.
Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640
[TBL] [Abstract][Full Text] [Related]
3. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.
Schmults CD; Karia PS; Carter JB; Han J; Qureshi AA
JAMA Dermatol; 2013 May; 149(5):541-7. PubMed ID: 23677079
[TBL] [Abstract][Full Text] [Related]
4. Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma.
Stevens JS; Murad F; Smile TD; O'Connor DM; Ilori E; Koyfman S; Vidimos A; Waldman AB; Ruiz ES
JAMA Dermatol; 2023 Jul; 159(7):728-735. PubMed ID: 37285135
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD
JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA
J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
[TBL] [Abstract][Full Text] [Related]
9. The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management.
Ruiz ES; Karia PS; Morgan FC; Schmults CD
J Am Acad Dermatol; 2017 Feb; 76(2):217-225. PubMed ID: 27707594
[TBL] [Abstract][Full Text] [Related]
10. Association of Nodal Metastasis and Mortality With Vermilion vs Cutaneous Lip Location in Cutaneous Squamous Cell Carcinoma of the Lip.
Wang DM; Kraft S; Rohani P; Murphy GF; Besaw RJ; Karia PS; Morgan FC; Schmults CD
JAMA Dermatol; 2018 Jun; 154(6):701-707. PubMed ID: 29801066
[TBL] [Abstract][Full Text] [Related]
11. Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis.
Massey PR; Wang DM; Murad F; Mulvaney P; Moore K; Okhovat JP; Russell-Goldman E; Lin WM; Piris A; Huilgol SC; Ruiz ES; Schmults CD
JAMA Dermatol; 2023 Dec; 159(12):1332-1338. PubMed ID: 37851425
[TBL] [Abstract][Full Text] [Related]
12. Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems.
Smile TD; Ruiz ES; Kus KJB; Murad F; Wei W; Xiong DD; Vidimos AT; Schmults CD; Koyfman SA
JAMA Dermatol; 2022 Apr; 158(4):390-394. PubMed ID: 35195668
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Tumor Classifications for Cutaneous Squamous Cell Carcinoma of the Head and Neck in the 7th vs 8th Edition of the AJCC Cancer Staging Manual.
Karia PS; Morgan FC; Califano JA; Schmults CD
JAMA Dermatol; 2018 Feb; 154(2):175-181. PubMed ID: 29261835
[TBL] [Abstract][Full Text] [Related]
14. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
15. Case-Control Study of Tumor Stage-Dependent Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed and Immunocompetent Patients.
Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
Dermatol Surg; 2019 Dec; 45(12):1467-1476. PubMed ID: 30964787
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
Que SKT; Zwald FO; Schmults CD
J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study.
Carter JB; Johnson MM; Chua TL; Karia PS; Schmults CD
JAMA Dermatol; 2013 Jan; 149(1):35-41. PubMed ID: 23324754
[TBL] [Abstract][Full Text] [Related]
18. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems.
Blechman AB; Carucci JA; Stevenson ML
Dermatol Surg; 2019 Sep; 45(9):1117-1124. PubMed ID: 30640779
[TBL] [Abstract][Full Text] [Related]
19. Tracking the risk factors associated with high-risk cSCC: A 10-year, Two-Institution, Greek study.
Dimonitsas E; Champsas G; Kakagia D; Stavrianos S; Roussos S; Doryforou O; Neamonitou F; Soura E; Kostopoulos E; Christofidou E; Papadopulos O; Thymara I; Papadopulos NA; Stratigos A; Korkolopoulou P
J BUON; 2021; 26(3):1148-1158. PubMed ID: 34268983
[TBL] [Abstract][Full Text] [Related]
20. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
